Atlas Trials

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

Clinical trial NCT06600906 · RECRUITING

Trial details

NCT number
NCT06600906
Sponsor
University of California, San Francisco
Status
RECRUITING
Study type
OBSERVATIONAL
Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaLocally Advanced Pancreatic Ductal Adenocarcinoma
Start date
2024-10-01
Primary completion
2030-08-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.